Esperion Therapeutics Inc. Ne position history
The shares of Esperion Therapeutics Inc. Ne that SOROS FUND MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q2: 757,358 shares, $2.4M, 0.03% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|